Document is current
Any future updates will be listed below
-
Authors
Banales, Jesus M. https://orcid.org/0000-0002-5224-2373
Rodrigues, Pedro M.
Affò, Silvia https://orcid.org/0000-0002-9731-3913
Andersen, Jesper B. https://orcid.org/0000-0003-1760-5244
Aspichueta, Patricia https://orcid.org/0000-0002-3553-1755
Boulter, Luke https://orcid.org/0000-0002-7954-6705
Bridgewater, John https://orcid.org/0000-0001-9186-1604
Calvisi, Diego F. https://orcid.org/0000-0002-6038-8567
Cardenas, Andres
Cardinale, Vincenzo
Carpino, Guido https://orcid.org/0000-0001-8570-2519
Coulouarn, Cédric https://orcid.org/0000-0002-5692-9586
Dopazo, Cristina
Edeline, Julien https://orcid.org/0000-0002-8289-7741
Fabris, Luca https://orcid.org/0000-0001-8538-6317
Folseraas, Trine
Forner, Alejandro https://orcid.org/0000-0002-9014-4950
Goeppert, Benjamin https://orcid.org/0000-0002-4135-9250
Heikenwalder, Mathias
Kendall, Timothy J. https://orcid.org/0000-0002-4174-2786
Khan, Shahid A. https://orcid.org/0000-0003-2538-0911
Klümpen, Heinz-Josef https://orcid.org/0000-0002-7290-1823
Koerkamp, Bas Groot https://orcid.org/0000-0003-1917-6973
Lamarca, Angela
Lindsey, Stacie
Lleo, Ana https://orcid.org/0000-0002-0561-7902
Luedde, Tom https://orcid.org/0000-0002-6288-8821
Macias, Rocio I. R. https://orcid.org/0000-0002-4748-0326
Morement, Helen https://orcid.org/0000-0001-6141-2816
Nault, Jean-Charles
Olaizola, Paula
Perugorria, Maria J.
Raggi, Chiara https://orcid.org/0000-0003-2473-3535
Rimassa, Lorenza https://orcid.org/0000-0001-9957-3615
Saborowski, Anna https://orcid.org/0000-0003-4857-4276
Valle, Juan W. https://orcid.org/0000-0002-1999-0863
Vithayathil, Mathew https://orcid.org/0000-0002-1457-4385
Vogel, Arndt https://orcid.org/0000-0003-0560-5538
Braconi, Chiara https://orcid.org/0000-0003-4835-1259
,
Sanchez, Abel
La Casta, Adelaida
Montano-Loza, Aldo J.
Elvevi, Alessandra
Parisi, Alessandro
Link, Alexander
Landa-Magdalena, Ana
Munoz, Andres
Turpin, Anthony
Ustav, Anu
Jusakul, Apinya
Valsan, Arun
Dwyer, Benjamin
Ungureanu, Bogdan S.
Sangro, Bruno
Schramm, Christoph
Neuzillet, Cindy
Fondevila, Constantino
Pinato, David J.
Malka, David
Balderramo, Domingo
Gutierrez, Elide
Lozano, Elisa
Boleslawski, Emmanuel
Estupinan, Enrique Carrera
Sparrelid, Ernesto
Gaudio, Eugenio
De La Tijera, Fatima Higuera
Rocha, Flavio
Troisfontaine, Florence
Ratti, Francesca
Lammert, Frank
Vidili, Gianpaolo
Sapisochin, Gonzalo
Lesinski, Gregory B.
Gores, Gregory
Jansson, Hannes
Malik, Hassan
Jonas, Jan Philipp
Ferrer, Javier Diaz
Vaquero, Javier
Marquardt, Jens U.
Santo, Joana Espírito
Adeva, Jorge
Erdmann, Joris
Marin, Jose J. G.
Roa, Juan Carlos
Busquets, Juli
Kupcinskas, Juozas
Zieniewicz, Krzysztof
Heij, Lara
Goff, Laura
Izquierdo-Sanchez, Laura
Da Fonseca, Leonardo G.
Maroni, Luca
Bujanda, Luis
McNamara, Mairéad G.
Carbone, Marco
Marzioni, Marco
Rengo, Marco
Deutsch, Maria Melanie
Ponz, Mariano
Strazzabosco, Mario
Peck-Radosavljevic, Markus
Cadamuro, Massimiliano
Salati, Massimiliano
Colombo, Massimo
Mandea, Matei
Avila, Matias A.
Evert, Matthias
Komuta, Mina
Borad, Mitesh
Bouattour, Mohamed
El-Kassas, Mohamed
Meneses-Medina, Monica I.
Niger, Monica
Verstegen, Monique
Bardeesy, Nabeel
Azad, Nilofer
Detry, Olivier
Scatton, Olivier
Padilla-Machaca, P. Martin
Acedo, Pilar
Olthof, Pim B.
Milkiewicz, Piotr
Guest, Rachel
Shroff, Rachna
Montal, Robert
Kelley, Robin Kate
Xue, Ruidong
Gradilone, Sergio
Maithel, Shishir K.
Vicent, Silvestre
Jirawatnotai, Siwanon
Caruso, Stefano
Roessler, Stephanie
Chan, Stephen L.
Pereira, Stephen P.
Macarulla, Teresa
Gruenberger, Thomas
Tian, Tian V.
Greten, Tim F.
Mocan, Tudor
Patel, Tushar
Mahmood, Umair
Cillo, Umberto
Megdanova, Vera
Lopez-Lopez, Victor
- License Information
-
More Information
Article History
Accepted: 31 October 2025
First Online: 10 December 2025
Competing interests
: J.M.B. declares research grants from Incyte, Albireo-Ipsen, Servier, Taiho and Cymabay-Gilead, personal fees for lectures from Servier, AstraZeneca, Eisai, Advanz and Ipsen, and consulting fees for Ipsen, Cymabay, AstraZeneca, Servier, Rubió Metabolomics and Jazz Pharmaceuticals. J.B.A. declares research grant support from Incyte and Adcendo and consultancies from Flagship Pioneering, AstraZeneca and QED. A.C. declares speaker and advisory honoraria from Boston Scientific and has received grant support from Boston Scientific. V.C. declares travel support from Advanz Pharma, speaker honoraria from Ipsen and Mirum, and grant support from Ipsen. J.E. declares consulting fees from MSD, Eisai, BMS, AstraZeneca, Bayer, Roche, Ipsen, Basilea, Merck Serono, Incyte, Servier, Beigene, Taiho, Boston Scientific and Guerbet, travel expenses from Amgen, and research funding (institutional) from BMS, Beigene, Boston Scientific, Exeliom Biosciences and SUMMIT. A.F. declares speaker honoraria from AstraZeneca, Roche and Boston Scientific and advisory honoraria from AstraZeneca, Incyte, Boston Scientific and Taiho. A. Lamarca declares travel and educational support from Ipsen, Pfizer, Bayer, AAA, SirtEx, Novartis, Mylan, Delcath Advanz Pharma and Roche, speaker honoraria from Merck, Pfizer, Ipsen, Incyte, AAA/Novartis, QED, Servier, AstraZeneca, EISAI, Roche, Advanz Pharma and MSD, advisory and consultancy honoraria from EISAI, Nutricia, Ipsen, QED, Roche, Servier, Boston Scientific, Albireo Pharma, AstraZeneca, Boehringer Ingelheim, GENFIT, TransThera Biosciences, Taiho and MSD, and principal investigator-associated Institutional Funding from QED, Merck, Boehringer Ingelheim, Servier, AstraZeneca, GenFit, Albireo Pharma, Taiho, TransThera and Roche; she is also a member of the Knowledge Network and NETConnect Initiatives funded by Ipsen. A. Lleo declares travel support from Ipsen, principal investigator-associated institutional funding form Mirum, GSK, Ipsen, Dr. Falk and Gilead, consulting fees from Advanz Pharma, GSK, Ipsen, Gilead, Dr. Falk, AlfaSigma, Takeda, and Albireo Pharma, and speaker fees from Gilead, Abbvie, MSD, Advanz Pharma, AlfaSigma, GSK and Incyte. L.R. declares consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Boehringer Ingelheim, Eisai, Elevar Therapeutics, Exelixis, Genenta, Guerbet, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology and Zymeworks, lecture fees from AstraZeneca, Bayer, Biologix, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche and Servier, travel expenses from AstraZeneca, Servier and research grants (to institution) from Abbvie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences and Zymeworks. A.S. received honoraria as a speaker from BMS, Roche, Servier, Ipsen, Lilly, AstraZeneca, MSD and Eisai, travel support from Ipsen, Servier, Pierre-Fabre, MSD and Eisai, and consulting fees from Eisai, MSD, Roche, Incyte and BMS. J.W.V. declares personal fees for consulting/advisory role from AstraZeneca, Incyte, Taiho Oncology, Servier, and Jazz Pharmaceuticals and fees to the institution for consulting/advisory role from RedX Pharma, Cogent Biosciences, Owkin, Jazz Pharmaceuticals and Oncosil.
Free to read: This content has been made available to all.
